BRUSSELS, and SOMERVILLE, Mass., March 15, 2023 /PRNewswire/ — UCB, a global biopharmaceutical company, and Aitia, the leader in the application of Causal AI and “Digital Twins” to discover and develop new drugs, today announced an early drug discovery collaboration focused on the…